The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients

Bibliography

• Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011;11(6):426-37
   PubMed Web of Science ®Google Scholar
• Jung K, Fleischhacker M, Rabien A. Cell-free DNA in the blood as a solid tumor biomarker–a critical appraisal of the literature. Clin Chim Acta 2010;411(21-22):1611-24
   PubMed Web of Science ®Google Scholar
• Frattini M, Gallino G, Signoroni S, Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer. Cancer Lett 2008;263(2):170-81
   PubMed Web of Science ®Google Scholar
• Gormally E, Hainaut P, Caboux E, Amount of DNA in plasma and cancer risk: a prospective study. Int J Cancer 2004;111(5):746-9
   PubMed Web of Science ®Google Scholar
• Wang BG, Huang HY, Chen YC, Increased plasma DNA integrity in cancer patients. Cancer Res 2003;63(14):3966-8
   PubMed Web of Science ®Google Scholar
• Stroun M, Lyautey J, Lederrey C, About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 2001;313(1-2):139-42
   PubMed Web of Science ®Google Scholar
• Jahr S, Hentze H, Englisch S, DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001;61(4):1659-65
   PubMed Web of Science ®Google Scholar
• Holdenrieder S, Holubec L Jr, Topolcan O, Circulating nucleosomes and cytokeratin 19-fragments in patients with colorectal cancer during chemotherapy. Anticancer Res 2005;25(3A):1795-801
   PubMed Web of Science ®Google Scholar
• Smith G, Carey FA, Beattie J, Mutations in APC, Kirsten-ras, and p53–alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci USA 2002;99(14):9433-8
   PubMed Web of Science ®Google Scholar
• Morlan J, Baker J, Sinicropi D. Mutation detection by real-time PCR: a simple, robust and highly selective method. PLoS One 2009;4(2):e4584
   PubMedGoogle Scholar
• Mouliere F, Gongora C, Guedj AS, Detection of high mutation load in circulating DNA from colorectal cancer patients with KRAS and BRAF point mutation enables the non-invasive molecular analysis of tumors. Cancer Research, in press
   Google Scholar
• Diehl F, Schmidt K, Choti MA, Circulating mutant DNA to assess tumor dynamics. Nat Med 2008;14(9):985-90
   PubMed Web of Science ®Google Scholar
• Leary RJ, Kinde I, Diehl F, Development of personalized tumor biomarkers using massively parallel sequencing. Sci Transl Med 2010;2(20):20ra14
   PubMed Web of Science ®Google Scholar
• Diehl F, Li M, Dressman D, Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci USA 2005;102(45):16368-73
   PubMed Web of Science ®Google Scholar
• Holdhoff M, Schmidt K, Donehower R, Diaz LA Jr. Analysis of circulating tumor DNA to confirm somatic KRAS mutations. J Natl Cancer Inst 2009;101(18):1284-5
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Uchida J, Nishino K, Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas. Clin Cancer Res 2011;17(24):7808-15
   PubMed Web of Science ®Google Scholar
• Chan KC, Zhang J, Hui AB, Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004;50(1):88-92
   PubMed Web of Science ®Google Scholar
• Umetani N, Giuliano AE, Hiramatsu SH, Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol 2006;24(26):4270-6
   PubMed Web of Science ®Google Scholar
• Deligezer U, Eralp Y, Akisik EE, Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy. Clin Chem Lab Med 2008;46(3):311-17
   PubMed Web of Science ®Google Scholar
• Thierry AR, Mouliere F, Gongora C, Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res 2010;38:6159-75
   PubMed Web of Science ®Google Scholar
• Mouliere F, Robert B, Arnau Peyrotte E, High fragmentation characterizes tumour-derived circulating DNA. PLoS One 2011;6(9):e23418
   PubMed Web of Science ®Google Scholar
• Thierry AR, Norris V, Molina F, Schmutz M. Lipoplex nanostructures reveal a general self-organization of nucleic acids. Biochim Biophys Acta 2009;1790(5):385-94
   PubMed Web of Science ®Google Scholar
• Gahan PB, Stroun M. The virtosome-a novel cytosolic informative entity and intercellular messenger. Cell Biochem Funct 2010;28(7):529-38
   PubMed Web of Science ®Google Scholar
• De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003;200(4):429-47
   PubMed Web of Science ®Google Scholar
• West NP, Dattani M, McShane P, The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. BJC 2010;102:1519-23
   PubMed Web of Science ®Google Scholar
• Choi JJ, Reich CF III, Pisetsky DS. The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology 2005;115(1):55-62
   PubMed Web of Science ®Google Scholar